Caleb Monroe

Innovations Unveiled at CES Day 2 Highlight AI, Robotics, and Energy Advances

Exhibitors showcase breakthroughs in AI-driven manufacturing, autonomous airport robots, adaptive cleaning devices, health monitoring, and fusion energy technologies

Day 2 of CES saw a surge in cutting-edge technology introductions, focusing on artificial intelligence integration across industries, autonomous syste...

US to Receive Up to 50 Million Barrels of Venezuelan Oil Under New Plan

Venezuelan authorities to transfer significant oil quantities to US storage, with proceeds managed by Washington

President Donald Trump announced a plan in which interim Venezuelan authorities will transfer between 30 million and 50 million barrels of oil to the ...

Ex-Trump Adviser Reveals Kremlin's 2019 Proposal Linking Venezuela and Ukraine

Russia hinted at a strategic exchange offering US free action in Venezuela for reciprocal freedom in Ukraine, stirring debate on geopolitical influence

In 2019, Russian officials subtly suggested a strategic exchange to the US involving Venezuela and Ukraine, implying a willingness to reduce support f...

Understanding and Applying Stock Market Dividend Capture Strategies for Income-Oriented Traders

For beginner and intermediate traders seeking to learn how dividend capture works, its risks, and practical steps to incorporate it into stock trading

Dividend capture strategies aim to generate income by buying stocks before their dividend ex-dividend date and selling shortly afterward. This guide e...

Medtronic Shares Rise After Analyst Upgrade on New Product Launches and Growth Prospects

William Blair Elevates Medtronic to Outperform as Upcoming Innovations Signal Potential Earnings Growth

Medtronic Plc's stock experienced an uptick following an upgrade by William Blair from Market Perform to Outperform. This reassessment reflects confid...

Johnson & Johnson Reports Encouraging Phase 2b Trial Outcomes for Lupus Drug Nipocalimab

Positive data from JASMINE study supports advancement to Phase 3 trials targeting systemic lupus erythematosus

Johnson & Johnson announced results from its Phase 2b JASMINE clinical trial assessing nipocalimab for systemic lupus erythematosus (SLE). The study a...

Anheuser-Busch InBev Commits $30 Million to Enhance Jacksonville Brewing Capacity

Expansion Focuses on Rising Demand for Popular Brands Including Michelob ULTRA

Anheuser-Busch InBev announced a $30 million investment aimed at upgrading brewing and packaging capabilities at its Jacksonville, Florida facility. T...

Ohio Police Appeal for Information in Double Homicide of Dentist and Wife

Security footage released to assist investigation into fatal shooting in Columbus home

Columbus authorities are investigating the fatal shooting of Dr. Spencer Tepe and his wife Monique, whose bodies were discovered in their home last we...

Joby Aviation Advances Pilot Training Initiatives Ahead of CES 2026

Preparing for Commercial Urban Air Mobility Launch with Enhanced Simulator Facilities and Industry Showcase

Joby Aviation is progressing its efforts to commercialize urban air mobility by installing advanced flight simulators for pilot certification and gear...

Positioning for Gen-3 Takeoff: Why BlackSky Could See Broader Gen-3 Adoption in 2026

A trade idea backing adoption-driven revenue inflection — entry, stops and targets included

BlackSky has moved from prototype launches to commercial deployments of its Gen-3 satellites and has already converted that capability into early cont...